Drug and clinical candidate information for calcr (ChEMBL ID: CHEMBL1832):

Molecule: CALCITONIN HUMAN
ChEMBL ID: CHEMBL4594248
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1986

Molecule: CALCITONIN SALMON
ChEMBL ID: CHEMBL3989767
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 1978

Molecule: SMC021
ChEMBL ID: CHEMBL3545415
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Protein

Molecule: CALCITONIN
ChEMBL ID: CHEMBL4594242
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
Drug and clinical candidate information for calcr (ChEMBL ID: CHEMBL2111189):

Molecule: PRAMLINTIDE ACETATE
ChEMBL ID: CHEMBL3833353
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005

Molecule: DAVALINTIDE
ChEMBL ID: CHEMBL2105635
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Protein
Drug and clinical candidate information for calcr (ChEMBL ID: CHEMBL2111190):

Molecule: PRAMLINTIDE ACETATE
ChEMBL ID: CHEMBL3833353
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005
Drug and clinical candidate information for calcr (ChEMBL ID: CHEMBL2364173):

Molecule: PRAMLINTIDE ACETATE
ChEMBL ID: CHEMBL3833353
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Protein
First Approval: 2005
